Published in Aktuelle Urol on November 01, 2006
Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide. Ger Med Sci (2009) 0.76
[Therapy sequence for renal cell carcinoma--new aspects!]. Aktuelle Urol (2007) 0.75
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Pyonephrosis: diagnosis and treatment. Br J Urol (1992) 1.97
EAU guidelines on prostate cancer. Eur Urol (2005) 1.88
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Sacral colpopexy with concurrent Burch colposuspension in patients with vaginal vault prolapse. Urol Int (2006) 1.60
A star in a 15.2-year orbit around the supermassive black hole at the centre of the Milky Way. Nature (2002) 1.56
Decision support software to help primary care physicians triage skin cancer: a pilot study. Arch Dermatol (2000) 1.53
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol (2003) 1.53
Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int (2006) 1.46
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Focal therapy in prostate cancer-report from a consensus panel. J Endourol (2010) 1.43
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.43
[Toxicity and efficacy of intermittent docetaxel chemotherapy for hormone refractory prostate cancer]. Aktuelle Urol (2009) 1.39
Aortic valve replacement: is the stentless xenograft an alternative to the homograft? Midterm results. Ann Thorac Surg (1999) 1.38
A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care (2002) 1.36
Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc Natl Acad Sci U S A (2004) 1.31
Innovation in detection of microparticles and exosomes. J Thromb Haemost (2013) 1.24
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. Eur J Cancer (2011) 1.22
Neuroradiology of cholesteatomas. AJNR Am J Neuroradiol (2010) 1.20
Giant calculus of the posterior urethra following recurrent penile urethral stricture. Urol Int (2002) 1.16
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients. Br J Cancer (2004) 1.15
Identification of steroid sulfate transport processes in the human mammary gland. J Clin Endocrinol Metab (2003) 1.13
[Cocaine-body-packing. Infrequent indication for laparotomy]. Chirurg (2003) 1.11
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients. World J Urol (2010) 1.08
Renal artery embolism: clinical features and therapeutic options. J Urol (1992) 1.08
Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease. Cancer (1997) 1.05
[Gender-specific characteristics and survival of renal cell carcinoma]. Urologe A (2008) 1.05
Ureteroscopy without routine balloon dilation: an outcome assessment. J Urol (1992) 1.04
Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology (1996) 1.03
K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr Pharm Des (2006) 1.03
Clinical experience with a new ultrasonic and LithoClast combination for percutaneous litholapaxy. BJU Int (2002) 0.99
Magnetic resonance imaging in the diagnosis of acute injured distal tibiofibular syndesmosis. Invest Radiol (1997) 0.99
Cardiac tamponade following pericarditis 18 days after catheter ablation of atrial fibrillation. Clin Res Cardiol (2010) 0.97
Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology (2001) 0.96
Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology (2011) 0.96
Influence of age on the signal transduction of T cells in mice. Int Immunol (1993) 0.96
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay. J Clin Oncol (2001) 0.95
Internally concealed cocaine: analytical and diagnostic aspects. J Forensic Sci (1995) 0.95
Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res (1990) 0.95
Somatotopic mapping of the human primary somatosensory cortex by fully automated tactile stimulation using functional magnetic resonance imaging. Neurosci Lett (1999) 0.95
Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis. Curr Med Chem (2008) 0.94
Factor XIII substitution in ulcerative colitis. Lancet (1995) 0.94
Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma. J Thorac Cardiovasc Surg (2006) 0.94
Local recurrence of an oncocytic adrenocortical carcinoma with ovary metastasis. J Urol (2001) 0.93
Quality-of-life issues in the treatment of testicular cancer. World J Urol (1999) 0.93
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. Br J Cancer (2010) 0.93
Anion channels in chara corallina tonoplast membrane: calcium dependence and rectification. J Membr Biol (1999) 0.93
The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. J Urol (2001) 0.92
Purulent corporeal cavernositis secondary to papaverine-induced priapism. J Urol (1991) 0.92
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron (1998) 0.92
Chordoid glioma of the third ventricle: confirmatory report of a new entity. Hum Pathol (1999) 0.91
Effects of toxins Pi2 and Pi3 on human T lymphocyte Kv1.3 channels: the role of Glu7 and Lys24. J Membr Biol (2001) 0.90
[European Association of Urology guidelines on urinary and male genital tract infections]. Urologe A (2003) 0.89
Viscocanalostomy versus trabeculectomy for primary open angle glaucoma: 4-year prospective randomized clinical trial. Eye (Lond) (2007) 0.89
Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches. J Cancer Res Clin Oncol (2005) 0.89
[Immunochemical studies on the problem of the "pregnancy zone". VI. Occurrence, identification, and demonstration of the pregnancy-specific protein in the pregnancy zone]. Arch Gynakol (1972) 0.89
Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis. Int J Cancer (2001) 0.89
Pseudo-pericardial tamponade after perforation of the right coronary artery. Heart (2004) 0.88
[Immunochemical studies of the problem of the "pregnancy zone". I. Antigravida immune serum]. Arch Gynakol (1969) 0.88
[Immunochemical studies on the problem of the "pregnancy zone". VII. Radioimmunological studies on the affinity of pregnancy zone proteins to estrogens in vitro]. Arch Gynakol (1972) 0.87
CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis. Oncogene (2010) 0.87
Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int Suppl (2001) 0.86
Relative advantage: a substitute for mean fitness in Fisher's fundamental theorem? J Theor Biol (1999) 0.86
Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model. Tumour Biol (2005) 0.86
Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial. J Urol (2003) 0.86
[Isolated epididymal torsion in dissociation of testis-epididymis]. Urologe A (2002) 0.86
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study. Breast Cancer Res Treat (2014) 0.85
Melanotic progonoma as a component of ovarian teratoma. Histopathology (2000) 0.85
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. Actas Urol Esp (2011) 0.85
[Guidelines for German urologists on diagnosis of benign prostate syndrome]. Urologe A (2003) 0.85
[Changes in blood rheology and microcirculation after preparatory combined thrombocytapheresis and plasmapheresis]. Beitr Infusionsther Transfusionsmed (1997) 0.85
Signet-ring cell ependymoma: case report with implications for pathogenesis and differential diagnosis. Pathol Res Pract (1999) 0.85
[Inhibition of lymphocyte transformation in vitro by protein fractions from the serum of pregnant women and placental extracts]. Zentralbl Gynakol (1973) 0.85
Apoptosis is triggered by the cyclic AMP signalling pathway in renal mesangial cells. FEBS Lett (1996) 0.85
[High-dose-rate brachytherapy of prostatic carcinoma with iridium 192]. Strahlenther Onkol (1992) 0.84
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. Folia Biol (Praha) (2003) 0.84